Dr Reddy`s gets tentative approval for Ziprasidone Hydrochloride
December 31, 2008 – 4:04 pm | 19 views
|
Dr Reddy`s Laboratories has received tentative approval from the US Food and Drug Administration (USFDA) to market Ziprasidone Hydrochloride capsules, in the strengths of 20 mg, 40 mg, 60 mg and 80 mg.
Ziprasidone Hydrochloride is prescribed to treat schizophrenia. It is also used for the short-term treatment of mania associated with bipolar disorder.
Dr Reddy`s is a vertically integrated, global pharmaceutical company with proven research capabilities and presence across the pharmaceutical value chain.
-IRIS.
Tags: bipolar disorder, Dr Reddy, Dr Reddy`s Laboratories, global pharmaceutical company, Indian Stock Marke News, schizophrenia, Stock Marke News, US Food and Drug Administration (USFDA), Ziprasidone Hydrochloride capsules
